What is the result of 759 illegal rebate-related drugs?

Kwon Chilseung, a member of Democratic Party of Korea asked the government to come up with measures

In the last five years, 759 drugs were counted as having received administrative disposition for illegal rebates.

 

Dong-A ST ranked first in the number of rebate disposals with 267 items, while CJ Healthcare ranked second with 114 items and Hanall Biopharma ranked third with 74 items.

 

Among them, only 96 items were suspended from application of medical care benefits.

 

On the 12th, Kwon Chilseung, a member of Democratic Party of Korea analyzed and released the data submitted by the MOHW.

 

According to the data, 759 items of 32 pharmaceutical companies have received illegal rebates over the past five years.

 

Of a total of 759 items, 532 were reduced in drug prices.

 

96 items were suspended from medical care benefits.

 

The remaining drug disposal details are 94 penalties, 34 drug price cuts and warnings, and 3 warnings.

 

The pharmaceutical company that received the most administrative disposition for drug rebates is Dong-A ST, which includes 267 items.

 

Next, CJ Healthcare followed with 114 items, Hanall Biopharma with 74 items, and Inist Biopharma with 49 items.

 

Kwon Chilseung, a member of Democratic Party of Korea, said, “For the rights that patients and citizens need to know, related information such as rebate providers, related drugs, and recipients should be continuously disclosed.” Also he added that administrative sanctions against providers should be strengthened in order to eradicate rebates.